Multi-Stay Study with Follow ups

8491-642 G3 3

Back To Current Studies

Multi-Stay Study with Follow ups

Study Number

8491-642 G3

Group

3

Gender

both

Age

18 - 70

Location

Dallas, Texas

Compensation

$17,062

Study Dates

Aug. 22, 2022 - Jan. 05, 2023

Additional Information

Labcorp Dallas, TX is recruiting for:

- Healthy Non-Smoking Adults, age 18-70

- Body Mass Index between 27-40

- Study involves 4 separate stays of 5 nights, plus 13 follow-up visits

- Compensation up to $17,062 may be provided for time and participation

- Receive up to $200 per qualified participant

Details

The purpose of this part of the study is to evaluate how much midazolam a drug used as a short-acting sedative, warfarin a drug used as a blood thinner, caffeine a drug used for mental alertness and migraine headaches, and their breakdown products get into the bloodstream after receiving multiple subcutaneous (under the skin) doses of the study drug.

Call Now to Schedule Your Screening Appointment! 

G3:

Check-in: Aug 22, Oct 13, Nov 10, Dec 8,
Check-out: Aug 27, Oct 18, Nov 15, Dec 13

OPV:  Sep 1, 8, 15, 29, Oct 6, 20, 27, Nov 3, 17, Dec 1, Jan 5

 

Calculate Your BMI!

Your Height:
ft / in
Your Weight:
lbs
Select Measurement System:

Your BMI: result